Junji Wasa
Impact in
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases
- Rheumatology top 5%
- Bone Tumor Diagnosis and Treatments
- Soft tissue tumor case studies
Papers in
-
- Sarcoma Diagnosis and Treatment 16
- Rheumatology 11
- Bone Tumor Diagnosis and Treatments 7
- Soft tissue tumor case studies 3
- Co-authors
- Yoshihiro Nishida (16 shared papers)Naoki Ishiguro (14 shared papers)Satoshi Tsukushi (13 shared papers)Hideshi Sugiura (5 shared papers)Yoji Shido (7 shared papers)Eisuke Arai (5 shared papers)Eiji Kozawa (10 shared papers)Hiroatsu Nakashima (2 shared papers)
- Journals
- International Journal of Cancer (2 papers)International Journal of Clinical Oncology (2 papers)Anticancer Research (1 paper)The Bone & Joint Journal (1 paper)Oncogene (1 paper)
- Partner nations
- JapanUnited StatesMalaysia
In The Last Decade
Junji Wasa
40 papers receiving 938 citations
Peers
Comparison fields: 5 of 68
- Neurology 195
- Rheumatology 192
- Cell Biology 208
- Pulmonary and Respiratory Medicine 271
- Oncology 135
Countries citing papers authored by Junji Wasa
This map shows the geographic impact of Junji Wasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Wasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Wasa more than expected).
Fields of papers citing papers by Junji Wasa
This network shows the impact of papers produced by Junji Wasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Wasa. The network helps show where Junji Wasa may publish in the future.
Co-authors
The 25 scholars most cited alongside Junji Wasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 236 | |
| 2 | 2011 | 131 | |
| 3 | 2011 | 78 | |
| 4 | 2010 | 68 | |
| 5 | 2010 | 67 | |
| 6 | 1991 | 54 | |
| 7 | 2011 | 44 | |
| 8 | 1997 | 35 | |
| 9 | 2019 | 31 | |
| 10 | 2017 | 19 | |
| 11 | 2017 | 17 | |
| 12 | 2018 | 16 | |
| 13 | The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model. | 2011 | 15 |
| 14 | 2020 | 13 | |
| 15 | 2011 | 13 | |
| 16 | 2008 | 12 | |
| 17 | 2020 | 10 | |
| 18 | 2011 | 10 | |
| 19 | Antitumor activity of an interleukin-2 monoclonal antibody in a murine osteosarcoma transplantation model. | 2012 | 9 |
| 20 | 2016 | 9 |
About Junji Wasa
Junji Wasa is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Surgery, Neurology and Oncology, having authored 42 papers that have together received 957 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (16 papers), Bone Tumor Diagnosis and Treatments (7 papers), Neurofibromatosis and Schwannoma Cases (5 papers), Management of metastatic bone disease (4 papers), Proteoglycans and glycosaminoglycans research (4 papers), Surgical site infection prevention (3 papers), Soft tissue tumor case studies (3 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Neurology (195 citations), Rheumatology (192 citations), Cell Biology (208 citations), Pulmonary and Respiratory Medicine (271 citations) and Oncology (135 citations). Junji Wasa has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Yoshihiro Nishida, Naoki Ishiguro, Satoshi Tsukushi, Hideshi Sugiura, Yoji Shido, Eisuke Arai, Eiji Kozawa, Hiroatsu Nakashima, Hiroshi Urakawa and Naohisa Futamura. Their work appears in journals such as International Journal of Cancer, International Journal of Clinical Oncology, Anticancer Research, The Bone & Joint Journal and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.